Business
WORK Medical Technology Group LTD Announces Pricing of $2.9 Million Registered Direct Offering
Hangzhou, China, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has entered into an agreement with several investors for the purchase and sale of 38,999,334 of the Company’s Class A ordinary share, par value $0.0005 per share (the “Shares”) (or pre-funded
About this update from Work Medical Technology Group Ltd
[{"type":"image","alt":"WORK Medical Technology Group LTD","displaySize":"","headline":null,"caption":"WORK Medical Technology Group LTD","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":115,"url":"https://media.zenfs.com/en/globenewswire.com/5c6f5c9b0e45051eb176e780086eddda"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/uUDJ_rnqH5.z3pxoEsuqXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5c6f5c9b0e45051eb176e780086eddda","width":300,"height":115}},"lazy":false},{"type":"text","content":"Hangzhou, China, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has entered into an agreement with several investors for the purchase and sale of 38,999,334 of the Company’s Class A ordinary share, par value $0.0005 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.075 per share in a registered direct offering (the “Offering”). The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.0005 per share.","length":755,"tagName":"p"},{"type":"text","content":"The gross proceeds to the Company of the Offering are expected to be approximately $2.9 million. The transaction is expected to close on or about September 26, 2025, subject to the satisfaction of customary closing conditions.","length":226,"tagName":"p"},{"type":"text","content":"Univest Securities, LLC is acting as the sole placement agent.","length":62,"tagName":"p"},{"type":"text","content":"The Offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-289943) previously filed by the Company and declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on September 15, 2025. A final prospectus supplement and accompanying prospectus describing the terms of the proposed Offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Univest Securities, LLC ...